Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives Consensus Recommendation of “Hold” from Analysts

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have earned an average rating of “Hold” from the sixteen research firms that are currently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a sell rating, six have issued a hold rating and eight have given a buy rating to the company. The average 1-year target price among brokers that have covered the stock in the last year is $22.75.

Several equities analysts recently issued reports on ACHC shares. Leerink Partnrs lowered Acadia Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, December 3rd. Weiss Ratings reissued a “sell (d)” rating on shares of Acadia Healthcare in a research report on Wednesday, October 8th. Guggenheim dropped their price objective on shares of Acadia Healthcare from $29.00 to $27.00 and set a “buy” rating for the company in a report on Monday, November 10th. Barclays reduced their target price on shares of Acadia Healthcare from $17.00 to $14.00 and set an “equal weight” rating on the stock in a report on Thursday, December 4th. Finally, Raymond James Financial set a $17.00 price target on shares of Acadia Healthcare in a research note on Wednesday, December 3rd.

Institutional Investors Weigh In On Acadia Healthcare

Hedge funds have recently bought and sold shares of the stock. Caitong International Asset Management Co. Ltd boosted its stake in shares of Acadia Healthcare by 11,218.2% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company’s stock valued at $38,000 after buying an additional 1,234 shares during the period. Allworth Financial LP raised its holdings in Acadia Healthcare by 676.4% in the second quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock valued at $31,000 after acquiring an additional 1,177 shares in the last quarter. EverSource Wealth Advisors LLC lifted its stake in Acadia Healthcare by 54.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after acquiring an additional 497 shares during the last quarter. Hantz Financial Services Inc. grew its holdings in Acadia Healthcare by 501.9% during the 3rd quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock worth $54,000 after acquiring an additional 1,822 shares in the last quarter. Finally, Covestor Ltd increased its position in shares of Acadia Healthcare by 56.0% in the 1st quarter. Covestor Ltd now owns 2,262 shares of the company’s stock valued at $69,000 after purchasing an additional 812 shares during the last quarter.

Acadia Healthcare Stock Performance

Shares of ACHC stock opened at $14.43 on Friday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.44 and a current ratio of 1.44. The firm has a market cap of $1.33 billion, a P/E ratio of 12.33, a P/E/G ratio of 3.58 and a beta of 0.91. The firm’s 50 day moving average price is $18.60 and its 200-day moving average price is $21.16. Acadia Healthcare has a one year low of $12.63 and a one year high of $47.08.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.71 by $0.01. Acadia Healthcare had a return on equity of 7.66% and a net margin of 3.29%.The company had revenue of $851.57 million for the quarter, compared to analyst estimates of $852.43 million. During the same quarter in the previous year, the company earned $0.91 earnings per share. The firm’s quarterly revenue was up 4.4% compared to the same quarter last year. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. As a group, equities research analysts predict that Acadia Healthcare will post 3.38 EPS for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.